肾旁及胸腹主动脉瘤开窗分支腔内修复的学习曲线
单中心回顾2007至2016年334例连续接受开窗分支腔内修复(F-BEVAR)的肾旁或胸腹主动脉瘤患者,按经验四分位(Q1-Q4)分析。尽管胸腹主动脉瘤比例和累及血管数增加,30天死亡率从Q1的6%降至Q4的0%,主要不良事件从60%降至29%,多项手术变量亦显著改善。
要点
- F-BEVAR学习曲线中,30天死亡率由Q1的6%降至Q4的0%,主要不良事件由60%降至29%。
- 估计失血量、手术时间、透视时间、对比剂用量和辐射剂量随经验积累显著下降。
- 手术时间、SVS总分和Q1经验是主要不良事件的独立预测因素。
核心结论
- F-BEVAR治疗肾旁和胸腹主动脉瘤的围手术期死亡率、主要不良事件、手术变量及再干预随经验积累显著改善,尽管动脉瘤病理复杂性增加。
研究设计与样本
- 单中心回顾性研究,纳入2007至2016年连续334例接受F-BEVAR的肾旁或胸腹主动脉瘤患者(255例男性,平均年龄75±7岁)。
- 按经验四分位(Q1-Q4)分析患者特征、器械设计、手术变量、30天死亡率和主要不良事件(MAEs)的趋势。
主要发现
- 178例(53%)为肾旁动脉瘤,156例(47%)为胸腹主动脉瘤;研究期间胸腹主动脉瘤比例和累及血管数显著增加。
- 30天死亡率从Q1的6%降至Q4的0%(P < .04),MAEs从Q1的60%降至Q4的29%(P < .001)。
- 估计失血量从Q1的1358±1517 mL降至Q4的486±520 mL(P < .001),总手术时间从325±116分钟降至248±92分钟(P < .001)。
- 总透视时间从Q1的121±59分钟降至Q4的85±39分钟(P < .001),对比剂用量从201±92 mL降至160±61 mL(P = .002)。
- 辐射剂量从Q2的4141±2570 mGy降至Q4的2543±1895 mGy(P < .001)。
关键数值与推荐
- MAEs的独立预测因素包括总手术时间(OR 1.6,95%CI 1.3-1.8,P < .001)、SVS总分(OR 1.1,95%CI 1.02-1.2,P = .009)和Q1经验(OR 3.0,95%CI 1.7-5.2,P < .001)。
临床怎么用
- F-BEVAR学习曲线中,早期经验(Q1)与较高的MAEs风险独立相关,应加强早期病例选择和围手术期管理。
- 随着经验积累,手术时间、失血量、透视时间和对比剂用量下降,可优化手术效率和安全性。
局限性
- 单中心回顾性研究,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to review the learning curve for fenestrated-branched endovascular aortic repair (F-BEVAR) of pararenal and thoracoabdominal aortic aneurysms (TAAAs). METHODS: We reviewed the clinical data of 334 consecutive patients (255 males, mean age 75 ± 7 years) who underwent F-BEVAR between 2007 and 2016 in a single institution. Outcomes were analyzed in four quartiles of experience (Q1-Q4). Study outcomes included trends in patient characteristics, device design, procedural variables, 30-day mortality, and major adverse events (MAEs). RESULTS: There were 178 patients (53%) treated for pararenal aneurysms and 156 (47%) for TAAAs. During the study period, there was a statistically significant increase in the proportion of TAAAs and in the number of vessels incorporated. Despite this, there was a steady decrease in 30-day mortality (6% in Q1 to 0% in Q4; P < .04) and in the rate of MAEs (60% in Q1 to 29% in Q4; P<.001). By linear regression analysis, there was significant decline in estimated blood loss (1358 ± 1517 mL in Q1 to 486 ± 520 mL in Q4; P < .001), total operating time (325 ± 116 minutes in Q1 to 248 ± 92 minutes in Q4; P < .001), total fluoroscopy time (121 ± 59 minutes in Q1 to 85 ± 39 minutes in Q4; P < .001), contrast volume (201 ± 92 mL in Q1 to 160 ± 61 mL in Q4; P = .002), and radiation dose (4141 ± 2570 mGy in Q2 to 2543 ± 1895 mGy in Q4; P < .001). Independent predictors of MAEs were total operating time (odds ratio [OR], 1.6; 95% confidence interval [CI], 1.3-1.8; P < .001), Society for Vascular Surgery total score (OR, 1.1; 95% CI, 1.02-1.2; P = .009), and quartile 1 (OR, 3.0; 95% CI, 1.7-5.2; P < .001). CONCLUSIONS: This study demonstrates significant improvement in perioperative mortality, MAEs, procedural variables, and secondary interventions in patients treated by F-BEVAR, despite the increase in complexity of aneurysm pathology during the study period. Also, better patient selection contributed to improve outcomes.
引用
- Mirza AK, Tenorio ER, Kärkkäinen JM, et al. Learning curve of fenestrated and branched endovascular aortic repair for pararenal and thoracoabdominal aneurysms. J Vasc Surg. 2020. PMID: 32081482. doi:10.1016/j.jvs.2019.09.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。